1. World Health Organization.Pharmacovigilance.www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/(accessed April 12 2019).
2. Thalidomide‐induced teratogenesis: History and mechanisms
3. The thalidomide embryopathy. An analysis from the UK;Quibell EP;Practitioner,1981
4. Medicines Act 1968.www.legislation.gov.uk/ukpga/1968/67(accessed April 12 2019).